Patent Assignment
Reel/Frame 020754/0184
Assignment of Assignor's Interest
Recorded: 2008-04-03
Pages: 9
Assignors
SCHENK, DALE B.
Executed: 2008-02-20
BUTTINI, MANUEL J.
Executed: 2008-02-11
CHILCOTE, TAMIE J.
Executed: 2008-01-30
GAMES, KATE DORA
Executed: 2008-02-11
Assignee
ELAN PHARMACEUTICALS, INC.
800 GATEWAY BLVD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Prevention and treatment of synucleinopathic and amyloidogenic disease
Application:
11/660,015 →
Publication:
US 2010/0031377
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 3, 2008
From: MASLIAH, ELIEZER; ROCKENSTEIN, EDWARD
To: UNIVERSITY OF CALIFORNIA
Reel/Frame 020754/0223 →
Corrective Assignment to Correct the Assignee Previously Recorded on Reel 020754 Frame 0223. Assignor(S) Hereby Confirms the Assignment of Assignors Interest.
Aug 10, 2009
From: MASLIAH, ELIEZAR; ROCKENSTEIN, EDWARD M.
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 023074/0558 →
Assignment of Assignor's Interest
Jan 11, 2012
From: ELAN PHARMACEUTICALS, INC.
To: CRIMAGUA LIMITED
Reel/Frame 027519/0009 →
Assignment of Assignor's Interest
Jan 11, 2012
From: CRIMAGUA LIMITED
To: JANSSEN ALZHEIMER IMMUNOTHERAPY
Reel/Frame 027519/0144 →